Readiness Strategies for Cell Therapy Commercial Manufacturing Workshop
READINESS STRATEGIES FOR CELL THERAPY COMMERCIAL MANUFACTURING WORKSHOP
Sponsored by: Hitachi Chemical Advanced Therapeutics Solutions
Section 1: Commercialization
This section of the workshop will discuss what strategies are being considered when commercializing cell therapies and current and future challenges faced to properly prepare for sustainable commercialization of these promising therapies.
Chair:
Sanjin Zvonić, Ph.D., Senior Director, Business Leader, Clinical and Commercial Manufacturing, Hitachi Chemical Advanced Therapeutics Solutions
Speakers:
Usman “Oz” Azam, M.D., President and CEO, Tmunity Therapeutics
Section 2: Global Footprint
This section of the workshop will discuss challenges related to global supply of cell therapies including global footprint and centralization strategies.
Chair:
Kazuchika Furuishi, Ph.D., Deputy General Manager, Regenerative Medicine Business Sector, Hitachi Chemical Co.
Speakers:
Devyn Smith, Ph.D., Chief Strategy Officer and Head of Operations, Sigilon Therapeutics
Kimberly Freeman, VP, Commercial Strategy and Planning, Adaptimmune
Видео Readiness Strategies for Cell Therapy Commercial Manufacturing Workshop канала Alliance for Regenerative Medicine
Sponsored by: Hitachi Chemical Advanced Therapeutics Solutions
Section 1: Commercialization
This section of the workshop will discuss what strategies are being considered when commercializing cell therapies and current and future challenges faced to properly prepare for sustainable commercialization of these promising therapies.
Chair:
Sanjin Zvonić, Ph.D., Senior Director, Business Leader, Clinical and Commercial Manufacturing, Hitachi Chemical Advanced Therapeutics Solutions
Speakers:
Usman “Oz” Azam, M.D., President and CEO, Tmunity Therapeutics
Section 2: Global Footprint
This section of the workshop will discuss challenges related to global supply of cell therapies including global footprint and centralization strategies.
Chair:
Kazuchika Furuishi, Ph.D., Deputy General Manager, Regenerative Medicine Business Sector, Hitachi Chemical Co.
Speakers:
Devyn Smith, Ph.D., Chief Strategy Officer and Head of Operations, Sigilon Therapeutics
Kimberly Freeman, VP, Commercial Strategy and Planning, Adaptimmune
Видео Readiness Strategies for Cell Therapy Commercial Manufacturing Workshop канала Alliance for Regenerative Medicine
Показать
Комментарии отсутствуют
Информация о видео
19 октября 2018 г. 0:21:48
01:31:36
Другие видео канала
![Panel: Cell Therapy Infrastructure & Manufacturing Requirements for Commercialization](https://i.ytimg.com/vi/quVKkF2SHkQ/default.jpg)
![Translating Stem Cell Therapies: From the Lab to Patients 2019](https://i.ytimg.com/vi/vvK_YmoQITc/default.jpg)
![New treatment horizon : Chimeric Antigen Receptor CAR T Cell Therapy](https://i.ytimg.com/vi/gmjLSeAXAmw/default.jpg)
![Cell & Gene State of the Industry Briefing 2021](https://i.ytimg.com/vi/eFuQPp4ubW8/default.jpg)
![GMP Ancillary Materials for Cell and Gene Therapy Manufacturing: What to consider..](https://i.ytimg.com/vi/4PFgkFhwH5Q/default.jpg)
![The Outlook for Gene Therapy in 2019](https://i.ytimg.com/vi/Bx7QhOyLK78/default.jpg)
![Bioprocessing Part 1: Fermentation](https://i.ytimg.com/vi/5eKdZ0dVCCo/default.jpg)
![The Promise of Stem Cell Therapy | Neil Neimark, MD | TEDxAshland](https://i.ytimg.com/vi/kFTN9AJAEQc/default.jpg)
![ARM's 2021 Cell & Gene State of the Industry Briefing](https://i.ytimg.com/vi/eJzwnaJFDSc/default.jpg)
![[Webinar] Process development to simplify manufacturing scale up of therapeutic viral vectors](https://i.ytimg.com/vi/vHjcJM5ZZVs/default.jpg)
![Jim Belzer - Case Studies: Scaling Cell Therapy Manufacturing](https://i.ytimg.com/vi/nekjlaedaAw/default.jpg)
![Good culture for your cells - Best practices for preventing contamination](https://i.ytimg.com/vi/H6PZlX-HQ9w/default.jpg)
![CAR-T Cell Therapies for CLL: How are the various techniques different?](https://i.ytimg.com/vi/wS5Dwa7pCFQ/default.jpg)
![Stem cell therapy -- beyond the headlines: Timothy Henry at TEDxGrandForks](https://i.ytimg.com/vi/tD0HSFe3mrY/default.jpg)
![Market Access Strategies for Advanced Therapies](https://i.ytimg.com/vi/mDZHMvjEzRA/default.jpg)
![Panel: Gene Therapy: The Outlook in 2018](https://i.ytimg.com/vi/DWgqxfpn3Pw/default.jpg)
![American Gene Technologies](https://i.ytimg.com/vi/zJA0rRm4VTg/default.jpg)
![Panel: When Does Investing in Cell and Gene Therapy Make Business Sense?](https://i.ytimg.com/vi/XciYH0FiuAY/default.jpg)
![Plasmid DNA in Cell and Gene Therapy: From Bench to Bedside | James Brown, Ph.D.](https://i.ytimg.com/vi/q6eEUNagDss/default.jpg)
![Amicus Therapeutics](https://i.ytimg.com/vi/L6h3KmFo7M4/default.jpg)